The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Open accessAbstract
VEGF is a secreted mitogen associated with angiogenesis and is also a potent vascular permeability factor. The biological role of VEGF in the ischemic brain remains unknown. This study was undertaken to investigate whether VEGF enhances cerebral microvascular perfusion and increases blood-brain barrier (BBB) leakage in the ischemic brain. Using magnetic resonance imaging (MRI), three-dimensional laser-scanning confocal microscope, and functional neurological tests, we measured the effects of administrating recombinant human VEGF(165) (rhVEGF(165)) on angiogenesis, functional neurological outcome, and BBB leakage in a rat model of focal cerebral embolic ischemia. Late (48 hours) administration of rhVEGF(165) to the ischemic rats enhanced angiogenesis in the ischemic penumbra and significantly improved neurological recovery. However, early postischemic (1 hour) administration of rhVEGF(165) to ischemic rats significantly increased BBB leakage, hemorrhagic transformation, and ischemic lesions. Administration of rhVEGF(165) to ischemic rats did not change BBB leakage and cerebral plasma perfusion in the contralateral hemisphere. Our results indicate that VEGF can markedly enhance angiogenesis in the ischemic brain and reduce neurological deficits during stroke recovery and that inhibition of VEGF at the acute stage of stroke may reduce the BBB permeability and the risk of hemorrhagic transformation after focal cerebral ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a pleiotropic growth factor, VEGF is responsible for multiple important physiological functions, particularly BBB permeability [44, 50, 51].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“Similar findings about the importance of timing for administration of a neurorestorative therapy for stroke have been reported for VEGF94 and modulators of matrix metallo proteinases.95”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Le Bihan, D., Breton, E., Lallemand, D., Grenier, P., Cabanis, E., & Laval-Jeantet, M. (1986) · Radiology · doi:10.1148/radiology.161.2.3763909 · Cited by 3,912
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE
Reese, T. S., & Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.34.1.207 · Cited by 2,629
Magnetic resonance imaging of perfusion using spin inversion of arterial water.
Williams, D. S., Detre, J. A., Leigh, J. S., & Koretsky, A. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.212 · Cited by 1,553
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. T., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,350
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L. H., Croll, S. D., Glazer, N. L., Holash, J. A., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,314
Peptide Growth Factors and Their Receptors
Arai, K., Battey, J. F., Sporn, M. B., & Roberts, A. B. (1991) · Medical Entomology and Zoology · Cited by 1,225
Breier, G., Albrecht, U., Sterrer, S., & Risau, W. (1992) · Development · doi:10.1242/dev.114.2.521 · Cited by 1,087
Takeshita, S., Zheng, L., Brogi, E., Kearney, M., Pu, L. L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,034
A functional MRI study of subjects recovered from hemiparetic stroke
Cramer, S. C., Nelles, G., Benson, R. R., Kaplan, J. D., Parker, R. A., Kwong, K. K., Kennedy, D. N., Finklestein, S. P., & Rosen, B. R. (1997) · Stroke · doi:10.1161/01.str.28.12.2518 · Cited by 1,019
Flagged first, then by citations
Research works printed but not linked: 8
- Carmeliet, 1997, Am J Physiol, 273, H2091
- Aiello, 1997, Invest Ophthalmol Vis Sci, 38, 1647
- Dvorak, 1995, Am J Pathol, 146, 1029
- Hatashita, 1990, Adv Neurol, 52, 327
- Lyden, 1993, Cerebrovasc Brain Metab Rev, 5, 1
- Dellian, 1996, Am J Pathol, 149, 59
- Cancilla, 1979, Lab Invest, 40, 74
- Criscuolo, 1990, Adv Neurol, 52, 469
Cited by
Sorted by citations
Items 101–200 of 1,000
An, C., Shi, Y., Li, P., Hu, X., Gan, Y., Stetler, R. A., Leak, R. K., Gao, Y., Sun, B., Zheng, P., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.12.002 · Cited by 204
Zhang, L., Zhang, R. L., Wang, Y., Zhang, C., Zhang, Z. G., Meng, H., & Chopp, M. (2005) · Stroke · doi:10.1161/01.str.0000158923.19956.73 · Cited by 198
Self-citationVascular Endothelial Growth Factor and Angiopoietins in Focal Cerebral Ischemia
Zhang, Z. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00149-9 · Cited by 198
“Administration of VEGF to rats starting 48 h after the onset of ischemia improves functional recovery, although it does not reduce infarct volume (Zhang et al. 2000).”
BackgroundInfluentialSelf-citationValable, S., Montaner, J., Bellail, A. C., Bérézowski, V., Brillault, J., Cecchelli, R., Divoux, D., MacKenzie, E. T., Bernaudin, M., Roussel, S., et al. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600148 · Cited by 191
“Indeed, an early administration of VEGF exacerbates blood–brain barrier (BBB) leakage, although a late administration of VEGF enhances angiogenesis (Zhang et al, 2000).”
BackgroundResultInfluentialMolecular Mechanisms for Early Brain Injury After Subarachnoid Hemorrhage
Ostrowski, R. P., Colohan, A. R. T., & Zhang, J. H. (2006) · Springer eBooks · doi:10.1007/978-0-387-30383-3_13 · Cited by 192
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
Helmy, A., Simoni, M. D., Guilfoyle, M., Carpenter, K., & Hutchinson, P. (2011) · Progress in neurobiology · doi:10.1016/j.pneurobio.2011.09.003 · Cited by 208
VEGF‐overexpressing transgenic mice show enhanced post‐ischemic neurogenesis and neuromigration
Wang, Y., Jin, K., Mao, X. O., Xie, L., Banwait, S., Marti, H. H., & Greenberg, D. A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21169 · Cited by 192
“…2005), or transgenic overexpression (Wang et al., 2005; this study), suggests that direct delivery is in some ways preferable to systemic administration, which may be accompanied by brain edema from increased vascular permeability and a poorer outcome (van Bruggen et al., 1999; Zhang et al., 2000).”
BackgroundShan, Y., Tan, S., Lin, Y., Liao, S., Zhang, B., Chen, X., Wang, J., Deng, Z., Zeng, Q., Zhang, L., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1638-6 · Cited by 191
Self-citationActivation and Role of Astrocytes in Ischemic Stroke
Shen, X.-Y., Gao, Z.-K., Han, Y., Yuan, M., Guo, Y., & Bi, X. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.755955 · Cited by 198
Neutrophils in traumatic brain injury (TBI): friend or foe?
Liu, Y., Li, S., & Dai, S.-S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1173-x · Cited by 197
“182], MMP8 and MMP9 [183], all of which are tightly connected with vessel growth and remodeling [184, 185].”
Lü, Y., Li, C., Chen, Q., Liu, P., Guo, Q., Zhang, Y., Chen, X., Zhang, Y., Zhou, W., Liang, D., et al. (2019) · Advanced Materials · doi:10.1002/adma.201808361 · Cited by 185
Manu, D. R., SLEVIN, M. A., Bărcuţean, L., Forró, T., Boghițoiu, T., & Bălașa, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417146 · Cited by 209
“The effects of astrocytic VEGF on ECs has been described previously as being partially attributed to NO generation in these cells, through a NO synthase/cGMP-dependent pathway [68–70].”
Targeting the Ischemic Penumbra
Ramos‐Cabrer, P., Campos, F., Sobrino, T., & Castillo, J. (2010) · Stroke · doi:10.1161/strokeaha.110.596684 · Cited by 184
Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia
Lee, S., Chu, K., Jung, K., Ko, S., Kim, E., Sinn, D.-I., Lee, Y., Lo, E. H., Kim, M., & Roh, J. K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.076 · Cited by 186
Krum, J. M., Mani, N., & Rosenstein, J. M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00615-7 · Cited by 185
Lee, T.-H., Avraham, H. K., Lee, S., & Avraham, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107348200 · Cited by 185
Manoonkitiwongsa, P. S., Jackson-Friedman, C., McMillan, P. J., Schultz, R. L., & Lyden, P. D. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00011 · Cited by 185
“Vascular endothelial growth factor expression is apparent in astrocytes for up to 2 weeks after stroke (Zhang et al., 2000).”
BackgroundCell based therapies for ischemic stroke: From basic science to bedside
Liu, X., Ye, R., Yan, T., Yu, S. P., Wei, L., Xu, G., Fan, X., Jiang, Y., Stetler, R. A., Liu, C., et al. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.007 · Cited by 179
“that early post-ischemic (1 h) administration of VEGF significantly exacerbated BBB leakage, hemorrhagic transformation, and ischemic lesions (Zhang et al., 2000).”
BackgroundAngiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke
Yang, Y. R., & Torbey, M. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200720173316 · Cited by 182
“1007/s00401-009-0483-6 PMID: 19142647 [15] Zhang, Z.”
BackgroundSun, Y., Jin, K., Childs, J. T., Xie, L., Mao, X. O., & Greenberg, D. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.10.016 · Cited by 178
“For example, VEGFA administration has neuroprotective effects in animal models of stroke (Hayashi et al., 1998; Sun et al., 2003; Zhang et al., 2000) and motor neuron disease (Azzouz et al.”
BackgroundDevelopment of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Li, J., Zheng, M., Shimoni, O., Banks, W. A., Bush, A. I., Gamble, J. R., & Shi, B. (2021) · Advanced Science · doi:10.1002/advs.202101090 · Cited by 202
The Janus Face of VEGF in Stroke
Geiseler, S. J., & Morland, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051362 · Cited by 179
“Togeth r, these mechanisms may aggravate neural damage [11,57].”
BackgroundInfluentialNeurovascular Proteases in Brain Injury, Hemorrhage and Remodeling After Stroke
Zhao, B., Tejima, E., & Lo, E. H. (2007) · Stroke · doi:10.1161/01.str.0000253500.32979.d1 · Cited by 177
Zimmerman, B., Rypma, B., Gratton, G., & Fabiani, M. (2021) · Psychophysiology · doi:10.1111/psyp.13796 · Cited by 179
“Thus, it is not clear whether these factors are solely beneficial to the microvasculature (Argaw et al., 2009, 2012; Nag, 2002; Zhang et al., 2000; Zhang & Chopp, 2002).”
BackgroundNeurorestorative treatment of stroke: Cell and pharmacological approaches
Chen, J., & Chopp, M. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.07.007 · Cited by 169
“VEGF165) to ischemic rats increased BBB leakage and infarction volume in the ischemic brain.(111) In contrast,”
BackgroundSelf-citationMinocycline-Preconditioned Neural Stem Cells Enhance Neuroprotection after Ischemic Stroke in Rats
Sakata, H., Niizuma, K., Yoshioka, H., Kim, G. S., Jung, J. E., Katsu, M., Narasimhan, P., Maier, C. M., Nishiyama, Y., & Chan, P. H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5686-11.2012 · Cited by 170
“These paracrine factors have a neuroprotective potential in animal ischemic stroke models (Wang et al., 1997; Schäbitz et al., 2000; Zhang et al., 2000; Saito et al., 2004).”
BackgroundPathogenic implications of iron accumulation in multiple sclerosis
Williams, R., Buchheit, C. L., Berman, N. E. J., & LeVine, S. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07536.x · Cited by 171
“VEGF enhances BBB leakage and induces angiogenesis (Zhang et al. 2000; Kaur and Ling 2008).”
BackgroundCell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia
Engelhardt, S., Patkar, S., & Ogunshola, O. O. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12489 · Cited by 168
“Similarly, VEGF administered i.v. increased infarct size when given early after ischaemia in rats but, in contrast, improved neurological function when given at later stages 2 days postischaemia (Zhang et al., 2000).”
BackgroundInfluentialYang, S., Bae, D., Kang, H. J., Gwag, B. J., Gho, Y. S., & Chae, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00111-8 · Cited by 178
“VEGF and its receptor, induced by hypoxia, enhance angiogenesis and cerebrovascular perfusion, and significantly improve neurological recovery in the brain ischemia [13,20,24,45].”
BackgroundVoss, M. W., Carr, L. J., Clark, R., & Weng, T. (2014) · Mental health and physical activity · doi:10.1016/j.mhpa.2014.01.001 · Cited by 164
Targeting Astrocytes for Stroke Therapy
Zhao, Y., & Rempe, D. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.004 · Cited by 163
Implications of vascular endothelial growth factor for postischemic neurovascular remodeling
Hermann, D. M., & Zechariah, A. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.100 · Cited by 162
“Four out of five studies with systemic (intraarterial, intravenous) VEGF delivery showed detrimental effects (Zhang et al, 2000; Abumiya et al, 2005; Kaya et al, 2005; Manoonkitiwongsa et al, 2004, 2006), reflected by an increase in brain injury in two studies, an increased hemorrhagic…”
BackgroundInfluentialMatsuno, H., Tsuchimine, S., O’Hashi, K., Sakai, K., Hattori, K., Hidese, S., Nakajima, S., Chiba, S., Yoshimura, A., Fukuzato, N., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01618-3 · Cited by 164
“In addition, VEGF is known to have an antidepressant effect through promoting brain angiogenesis and neurogenesis [86, 87].”
BackgroundRepairing brain after stroke: A review on post-ischemic neurogenesis
WILTROUT, C., Lang, B. T., Yan, Y., Dempsey, R. J., & Vemuganti, R. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.011 · Cited by 164
Gu, Y. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/222 · Cited by 162
“The activations of eNOS and nNOS generally produce a small amount of NO (at nanomole level ) (71, 72), but the iNOS subtype is calcium independent and produce large amounts of NO (at micromole level) (73).”
BackgroundHypoxia‐induced astrocytic reaction and increased vascular permeability in the rat cerebellum
Kaur, C., Sivakumar, V., Zhang, Y., & Ling, E. (2006) · Glia · doi:10.1002/glia.20420 · Cited by 160
“Furthermore, increased expression of VEGF has been suggested as a factor underlying disruption of the blood–brain barrier (BBB, Mayhan, 1999; Zhang et al., 2000, 2002).”
BackgroundVascular Endothelial Growth Factor (VEGF) in Seizures:
Croll, S. D., Goodman, J. H., & Scharfman, H. E. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-6376-8_4 · Cited by 158
“In cerebral ischemia, VEGF has been shown to worsen post-ischemic edema and VEGF antagonism protects against damage.(108,109) However, there is also evidence that anti-inflammatory agents could lead to more post-seizure cell damage.”
BackgroundEndothelial response to hypoxia: physiologic adaptation and pathologic dysfunction
Ten, V. S., & Pinsky, D. J. (2002) · Current Opinion in Critical Care · doi:10.1097/00075198-200206000-00008 · Cited by 160
Zhang, Z. G., Zhang, L., Croll, S. D., & Chopp, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00175-6 · Cited by 160
Self-citationKaya, D., Özdemir, Y., Yemişçi, M., Tuncer, N., Aktan, S., & Dalkara, T. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600109 · Cited by 160
“In contrast to intracerebroventricular administration, intravenously administered VEGF significantly increased the infarct volume to 73712 mm3 in line with a previous report (Zhang et al, 2000).”
BackgroundResultInfluentialExosomes and stem cells in degenerative disease diagnosis and therapy
Chang, Y.-H., Wu, K.-C., Harn, H.-J., Lin, S.-Z., & Ding, D.-C. (2018) · Cell Transplantation · doi:10.1177/0963689717723636 · Cited by 159
Neurogenesis in the Adult Ischemic Brain: Generation, Migration, Survival, and Restorative Therapy
Zhang, R. L., Zhang, Z. G., & Chopp, M. (2005) · The Neuroscientist · doi:10.1177/1073858405278865 · Cited by 160
Self-citationNowacka, M. M., & Obuchowicz, E. (2012) · Neuropeptides · doi:10.1016/j.npep.2011.05.005 · Cited by 157
“Cellular stress induced, for instance, by hypoglycemia, low pH, oxidative stress, may be another activator of VEGF expression (Zhang et al., 2000).”
BackgroundLee, H. J., Lim, I. J., Lee, M. C., & Kim, S. U. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22474 · Cited by 160
“New vessel formation mediated by BDNF will improve blood supply to the injured region, thereby efficiently providing oxygen and nutrients to the degenerating and regenerating neurons in the injured brain (Zhang et al., 2000; Sun et al., 2003).”
BackgroundIschemic stroke and neurogenesis in the subventricular zone
Zhang, R. L., Zhang, Z. G., & Chopp, M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.027 · Cited by 166
“…progenitor differentiation and neuroblast migration (Leventhal et al., 1999; Lin et al., 2000; Morris et al., 2000; Palmer et al., 2000; Zhang et al., 2000; Zhang et al., 2001b; Jin et al., 2002; Zhang and Chopp, 2002; Zhang et al., 2002; Shen et al., 2004; Greenberg and Please send…”
BackgroundSelf-citationNarasimhan, P., Liu, J., Song, Y. S., Massengale, J. L., & Chan, P. H. (2009) · Stroke · doi:10.1161/strokeaha.108.534644 · Cited by 156
Hayakawa, K., Nakano, T., Irie, K., Higuchi, S., Fujioka, M., Orito, K., Iwasaki, K., Jin, G., Lo, E. H., Mishima, K., et al. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.257 · Cited by 159
Venkat, P., Chopp, M., & Chen, J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005819 · Cited by 165
“Although VEGF is beneficial when administered before stroke(40) or at a delayed time point after stroke,(41) in the acute phase of stroke, VEGF increases BBB leakage, cerebral hemorrhage, and infarction volume.(41) DM rats suffer from vascular damage, which is aggravated after an ischemic insult; the effects of VEGF m…”
BackgroundSelf-citationInvestigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI
Jiang, Q., Zhang, Z. G., Ding, G., Zhang, L., Ewing, J. R., Wang, L., Zhang, R., Li, L., Lü, M., Meng, H., et al. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.06.063 · Cited by 152
“in combination with 3D laser scanning confocal microscopic images, we have demonstrated that cell therapy enhanced angiogenesis correlates to increased CBF at the ischemic boundary (Zhang et al., 2000).”
BackgroundSelf-citationAngiogenesis in the ischemic core: A potential treatment target?
Kanazawa, M., Takahashi, T., Ishikawa, M., Onodera, O., Shimohata, T., & del Zoppo, G. J. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19834158 · Cited by 157
Angiogenesis-regulating microRNAs and Ischemic Stroke
Yin, K., Hamblin, M., & Chen, Y. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990016 · Cited by 153
Oligodendrogenesis after cerebral ischemia
Zhang, R., Chopp, M., & Zhang, Z. G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00201 · Cited by 159
“…by activated cerebral endothelial cells in the ischemic boundary region are likely involved in OPC migration to peri-infarct gray and white matters (Zhang et al., 2000; Imitola et al., 2004; Ohab et al., 2006; Robin et al., 2006; Hayakawa et al., 2012; Bain et al., 2013; de Castro et al., 2013).”
BackgroundSelf-citationVEGF Signaling in Neurological Disorders
Shim, J. W., & Madsen, J. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010275 · Cited by 149
“Stroke (collateral forming phase) ↓ VEGF (cerebral cortex) yes [17] r ↑ VEGF (cerebral cortex) reparative angiogenesis yes [20] m”
BackgroundInfluentialEffects of vascular endothelial growth factor in ischemic stroke
Ma, Y., Zechariah, A., Qu, Y., & Hermann, D. M. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23088 · Cited by 147
“One study showed an increased permeability of the blood–brain barrier to gadolinium, Evans blue, and fluorescein isothiocyanate (FITC) dextran (Zhang et al., 2000), and one study showed an increased albumin extravasation (Kaya et al., 2005; Table II).”
BackgroundInfluentialPerlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents
Lee, B., Clarke, D. N., Al-Ahmad, A. J., Kahle, M., Parham, C. L., Auckland, L. D., Shaw, C. S., Fidanboylu, M., Orr, A. W., Ogunshola, O. O., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46358 · Cited by 147
Vascular Endothelial Growth Factor Regulates the Migration of Oligodendrocyte Precursor Cells
Hayakawa, K., Pham, L. A. T., Som, A. T., Lee, B. J., Guo, S., Lo, E. H., & Arai, K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1944-11.2011 · Cited by 151
“Hence, the ability of VEGF treatments to improve neurological deficits in rodent stroke models may involve not only angiogenesis (Zhang et al., 2000; Sun et al., 2003), but also oligodendrogenesis and plasticity.”
BackgroundHypoxia Preconditioning in the Brain
Ran, R., Xu, H., Lu, A., Bernaudin, M., & Sharp, F. R. (2005) · Developmental Neuroscience · doi:10.1159/000085979 · Cited by 145
“One of the challenges for the future is determining whether hyp oxia, HIF-induced genes, Egr-1-induced genes, or even specific target genes will be the most protective against ischemia in addition to having the fewest side effects. For example, even though VEGF induces new blood vessels, it worsens the outcome when gi…”
BackgroundThe neuroprotective function of vascular endothelial growth factor (VEGF).
Góra-Kupilas, K., & Jośko, J. (2005) · PubMed · Cited by 143
Wu, J., Sun, Z., Sun, H., Wu, J., Weisel, R. D., Keating, A., Li, Z., Feng, Z., & Li, R. (2007) · Cell Transplantation · doi:10.3727/000000007783472435 · Cited by 145
Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke
Rust, R., Grönnert, L., Gantner, C., Enzler, A., Mulders, G., Weber, R., Siewert, A., Limasale, Y. D. P., Meinhardt, A., Maurer, M. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905309116 · Cited by 142
“Clinically, treatments to enhance poststroke angiogenesis, for example by VEGF (8), are lacking or not feasible, mainly due to side effects, despite preclinical evidence for beneficial effects (7).”
BackgroundOhlin, K. E., Francardo, V., Lindgren, H. S., Sillivan, S. E., O’Sullivan, S. S., Luksik, A. S., Vassoler, F. M., Lees, A. J., Konradi, C. L., & Cenci, M. A. (2011) · Brain · doi:10.1093/brain/awr165 · Cited by 140
“This response can be viewed as both protective and potentially harmful because, while increasing tissue vascularization, VEGF also induces blood–brain barrier leakage and inflammation (Zhang et al ., 2000; Krum et al ., 2002).”
BackgroundVEGF and VEGF Receptor Expression after Experimental Brain Contusion in Rat
Sköld, M. K., von Gertten, C., Sandberg-Nordqvist, A.-C., Mathiesen, T. I., & Holmin, S. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.353 · Cited by 142
“VEGF expression of neurons in response to hypoxia has a paracrine/autocrine role for maintenance of neurons (Ogunshola et al., 2002) and the administration of VEGF in vivo after MCAO occlusion can have beneficial effects (Sun et al., 2003).”
InfluentialAngiogenic growth factors in the pathophysiology of a murine model of acute lung injury
Karmpaliotis, D. I., Kosmidou, I., Ingenito, E. P., Hong, K., Malhotra, A., Sunday, M. E., & Haley, K. J. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00048.2002 · Cited by 141
“VEGF is a potent endothelial cell mitogen (16) that, through binding to its receptor, VEGF-R2/fetal liver kinase (flk), induces capillary leakage (19) and fluid accumulation in models of ischemic organ injury (27) or systemic inflammation (22).”
BackgroundResultBlood-neural barrier: its diversity and coordinated cell-to-cell communication
Choi, Y.-K., & Kim, K. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.5.345 · Cited by 140
“barriers permeability (47), and is a survival factor that pro-”
Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke
Hayakawa, K., Qiu, J., & Lo, E. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05728.x · Cited by 144
Angiogenic Recruitment of Pericytes from Bone Marrow after Stroke
Kokovay, E., Li, L., & Cunningham, L. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600214 · Cited by 139
“These vessels were thin walled and dilated, indicative of new vessel growth (Zhang et al, 2000).”
BackgroundBiological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke
He, Q., Ma, Y., Liu, J., Zhang, D., Ren, J., Zhao, R., Chang, J., Guo, Z., & Yang, Y. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.801985 · Cited by 142
“Conversely, administration of VEGF 1 h after ischemia significantly exacerbates the neurological deficits (32, 33).”
BackgroundMolecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor
Sun, F., & Guo, X. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20321 · Cited by 137
“Topical administration of VEGF to the surface of rat brains reduces infarct size (Hayashi et al., 1998; Sun et al., 2003), whereas intravenous injection of VEGF improves neuronal outcomes (Zhang et al., 2000).”
BackgroundArteriovenous malformation in the adult mouse brain resembling the human disease
Walker, E. J., Su, H., Shen, F., Choi, E., Oh, S. P., Chen, G. H., Lawton, M. T., Kim, H., Chen, Y., Chen, W., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22348 · Cited by 136
“There were a few fluorescent beads in the lung of AAV-VEGF-injected control mice, consistent with vascular dilation present in VEGF-treated tissues.(27) Second, we perfused the animals with latex through the left ventricle of the heart.”
MethodLee, C. Z., Xue, Z., Zhu, Y., Yang, G., & Young, W. L. (2007) · Stroke · doi:10.1161/strokeaha.106.481515 · Cited by 136
Zhang, L., Zhang, Z., Zhang, R. L., Cui, Y., LaPointe, M. C., Silver, B., & Chopp, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.028 · Cited by 135
Self-citationBaburamani, A. A., Ek, C. J., Walker, D. W., & Castillo-Meléndez, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00424 · Cited by 144
“…(Kim et al., 1993; Breier and Risau, 1996; Banerjee et al., 1997; Breier, 2000), wound healing (Bates and Jones, 2003; Otrock et al., 2007), diabetic retinopathy (Boulton et al., 1998; Aiello, 2005), and following stroke (Krupinski et al., 1994; Zhang et al., 2000; del Zoppo and Mabuchi, 2003).”
BackgroundInfluentialChen, J., Li, Y., Zhang, R., Katakowski, M., Gautam, S. C., Xu, Y., Lü, M., Zhang, Z., & Chopp, M. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.080 · Cited by 134
Self-citationSuzuki, Y., Nagai, N., & Umemura, K. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00002 · Cited by 140
“Frontiers in Cellular Neuroscience | www.frontiersin.org 2 January 2016 | Volume 10 | Article 2 rt-PA Promotes ICB Through Mechanisms”
BackgroundMethodCrosstalk Between the Oxidative Stress and Glia Cells After Stroke: From Mechanism to Therapies
Zhu, G., Wang, X., Chen, L., Lenahan, C., Fu, Z., Fang, Y., & Yu, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.852416 · Cited by 138
Cerebral edema after ischemic stroke: Pathophysiology and underlying mechanisms
Gu, Y., Zhou, C., Piao, Z. H., Yuan, H., Jiang, H., Wei, H., Zhou, Y., Nan, G., & Ji, X. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.988283 · Cited by 149
“A previous study showed that early administration of recombinant VEGF after experimental rat stroke increased edema formation (Zhang et al., 2000).”
MethodVascular Endothelial Cell-specific MicroRNA-15a Inhibits Angiogenesis in Hindlimb Ischemia
Yin, K., Olsen, K. F., Hamblin, M., Zhang, J., Schwendeman, S. P., & Chen, Y. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364414 · Cited by 136
Manoonkitiwongsa, P. S., Schultz, R. L., McCreery, D. B., Whitter, E. F., & Lyden, P. D. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000126236.54306.21 · Cited by 131
“…neurogenesis, chemotaxis of inflammatory cells, and inhibition of apoptosis (Bates and Harper, 2002; Carmeliet et al., 1996; Ferrara and Gerber, 2001; Forstreuter et al., 2002; Lafuente et al., 2002; Rosenstein et al., 1998; Sun et al., 2003; van Bruggen et al., 1999; Zhang et al., 2000).”
BackgroundMethodInfluentialNeuroinflammation, Mast Cells, and Glia: Dangerous Liaisons
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2017) · The Neuroscientist · doi:10.1177/1073858416687249 · Cited by 133
“Indeed, VEGF administration shortly after stroke increases vascular leakage and brain infarction (Zhang and others 2000).”
Ferraris, C., Cavalli, R., Panciani, P. P., & Battaglia, L. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s231479 · Cited by 131
Svensson, B., Peters, M., König, H., Poppe, M., Levkau, B., Rothermundt, M., Arolt, V., Kögel, D., & Prehn, J. H. M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000037988.07114.98 · Cited by 131
“However, VEGF may also enhance ischemic injury due to its ability to increase blood–brain barrier leakage, particularly during the early stage of an ischemic insult (van Bruggen et al., 1999; Zhang et al., 2000).”
BackgroundToyama, K., Honmou, O., Harada, K., Suzuki, J., Houkin, K., Hamada, H., & Kocsis, J. D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.010 · Cited by 131
Barteczek, P., Li, L., Ernst, A., Böhler, L.-I., Marti, H. H., & Kunze, R. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15624933 · Cited by 129
“However, both factors also have undesired side effects when given as treatment, such as erythrocytosis and vascular leakage leading to brain edema.(34,45) Understanding the in vivo situation where not only a single factor but the whole hypoxia-induced pathway is activated might help to find alternative therapeutic str…”
BackgroundResultInfluentialMin, J., Lee, Y., Kim, J. H., Kim, Y., Kim, S. W., Lee, S.-Y., Gho, Y. S., Oh, G. T., & Kwon, Y. (2005) · Circulation Research · doi:10.1161/01.res.0000155330.07887.ee · Cited by 131
Avraham, H. K., Jiang, S., Fu, Y., Nakshatri, H., Ovadia, H., & Avraham, S. (2013) · The Journal of Pathology · doi:10.1002/path.4304 · Cited by 127
Venkat, P., Chopp, M., Zacharek, A., Cui, C., Zhang, L., Li, Q., Lü, M., Zhang, T., Liu, A., & Chen, J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.002 · Cited by 128
Self-citationThe Neurovascular Unit: Effects of Brain Insults During the Perinatal Period
Bell, A., Miller, S., Castillo-Meléndez, M., & Malhotra, A. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01452 · Cited by 131
Li, J., Zhang, Q., Wang, W., Lin, F., Wang, S., & Zhao, J. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10138-5 · Cited by 128
Locatelli, F., Bersano, A., Ballabio, E., Lanfranconi, S., Papadimitriou, D. A., Strazzer, S., Bresolin, N., Comi, G. P., & Corti, S. P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8346-1 · Cited by 125
Local Hemodynamics Dictate Long-Term Dendritic Plasticity in Peri-Infarct Cortex
Mostany, R., Chowdhury, T. G., Johnston, D. G., Portonovo, S. A., Carmichael, S. T., & Portera‐Cailliau, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3908-10.2010 · Cited by 127
“For example, enhancement of cerebral angiogenesis at the ischemic boundary is thought to be an essential ingredient of stroke plasticity (Zhang and Chopp, 2009) and drugs that enhance angiogenesis may prove beneficial in stroke therapy (Zhang et al., 2000).”
BackgroundZechariah, A., ElAli, A., Doeppner, T. R., Jin, F., Hasan, M. R., Helfrich, I., Mies, G., & Hermann, D. M. (2013) · Stroke · doi:10.1161/strokeaha.111.000240 · Cited by 125
“In animal models of ischemic stroke, VEGF-induced angiogenesis has been shown to result in structural neuroprotection and functional neurological recovery.(5,6) Whether the preservation of ischemic tissue was a consequence of enhanced cerebral blood flow (CBF) or of neuroprotective effects of VEGF was unclear.”
BackgroundNon-Coding RNA in Acute Ischemic Stroke: Mechanisms, Biomarkers and Therapeutic Targets
Wang, S., Liu, Z., & Shi, Z. (2018) · Cell Transplantation · doi:10.1177/0963689718806818 · Cited by 123
Rosell, A., Morancho, A., Navarro-Sobrino, M., Martínez-Sáez, E. A., Hernández‐Guillamón, M., Lope‐Piedrafita, S., Barceló, V., Borràs, F. E., Peñalba, A., García‐Bonilla, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073244 · Cited by 122
“In fact, it has already been shown in animal models of stroke that the late (but not early) administration of growth factors such as VEGF enhanced angiogenesis in the ischemic brain by improving neurological recovery [28].”
Targeting the blood-brain barrier for the delivery of stroke therapies
D’souza, A. A., Dave, K. M., Stetler, R. A., & Manickam, D. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.015 · Cited by 125
RETRACTED: HIF-1α inhibition ameliorates neonatal brain injury in a rat pup hypoxic–ischemic model
Chen, W., Jadhav, V. R., Tang, J., & Zhang, J. H. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.020 · Cited by 121
RetractedLi, L., Jiang, Q., Zhang, L., Ding, G., Zhang, Z. G., Li, Q., Ewing, J. R., Lü, M., Panda, S., Ledbetter, K. A., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2006.10.098 · Cited by 119
“Restoration of cerebral circulation is important for functional recovery after a stroke (Zhang et al., 2000).”
BackgroundSelf-citationImplicating endothelial cell senescence to dysfunction in the ageing and diseased brain
Graves, S. I., & Baker, D. J. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13403 · Cited by 118
Matrix metalloproteinases as drug targets in ischemia/reperfusion injury
Dejonckheere, E., Vandenbroucke, R. E., & Libert, C. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.009 · Cited by 120
Zhang, L., Li, Y., Zhang, C., Chopp, M., Gosiewska, A., & Hong, K. (2011) · Stroke · doi:10.1161/strokeaha.110.593129 · Cited by 118
Self-citationKaur, C., Sivakumar, V., Yong, Z., Lü, J., Foulds, W., & Ling, E. A. (2007) · The Journal of Pathology · doi:10.1002/path.2195 · Cited by 117
Metadata
- Authors
- Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M.
- Affiliations
- Henry Ford Health (US)
- Henry Ford Hospital (US)
- Genentech (US)
- Oakland University (US)
- Corresponding author
- Chopp, Michael
- Venue
- Journal of Clinical Investigation
- Published
- 2000-10-01
- Volume
- 106
- Issue
- 7
- Pages
- 829-838
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC517814
- OpenAlex
- W2084498863
- Cited by
- 1,296
- References
- 75
- Citations by year
- 2026: 32 · 2025: 49 · 2024: 53 · 2023: 52 · 2022: 64 · 2021: 73 · 2020: 58 · 2019: 42 · 2018: 59 · 2017: 59 · 2016: 61 · 2015: 49 · 2014: 70 · 2013: 70 · 2012: 64
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns033627-08)
- National Institute of Neurological Disorders and Stroke (P01NS23393, R01NS-33627, P01NS023393)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- vascular endothelial growth factor, angiogenesis, blood-brain barrier disruption, cerebral ischemia, hemorrhagic transformation, ischemic penumbra, neurological recovery, VEGF inhibition, stroke
- MeSH terms
- Animals, Blood-Brain Barrier, Brain Ischemia, Image Processing, Computer-Assisted, Lymphokines, Magnetic Resonance Imaging, Male, Microcirculation, Neovascularization, Pathologic, Regional Blood Flow, Endothelial Growth Factors, Treatment Outcome, Rats, Wistar, Stroke, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review